Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04490031 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 28, 2020 (before its estimated December 31, 2020 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is a study evaluating the usage of Ketamine as sedative agent in ERCP. The usage of Ketamine will be compared to the standard sedation in our center, which is Midazolam in combination with Pethidine as analgesia.
Trial Details
NCT Number NCT04490031
Lead Sponsor Universiti Kebangsaan Malaysia Medical Centre
Conditions
(from sponsor)		 Ketamine Adverse Reaction
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov